Researchers at the University of California San Diego School of Medicine have found that individuals with colon cancer and a documented history of high cannabis use were more than 20 times more ...

A Kaiser Permanente colon cancer screening initiative put a huge dent in cancer cases and deaths over two decades, a new study says. The systematic outreach program doubled colon cancer screening ...

"The findings offer the first real solution in two decades for managing this rash, which frequently impacts patients receiving targeted therapies for colorectal cancer," said study co-author Zev ...

Colon cancer cases have been increasing among younger adults, and now researchers think they've identified a potential culprit. A bacterial toxin called colibactin, produced by certain strains of E.

Exposure to colibactin in early childhood imprints a distinct genetic signature on the DNA of colon cells that can increase the risk of colorectal cancer. Young adults diagnosed with colorectal ...

A sharp rise in colorectal cancer among adults younger than 50 has renewed focus on diet, food safety and other lifestyle risks, underscoring the complex web of environmental and behavioral ...

Since the mid 2000s, studies have repeatedly shown that this toxin can inflict distinct DNA damage on colon cells that’s difficult to repair and can eventually lead to the development of cancer. T ...

At 39, she learned she had Stage 3 colorectal cancer. In late 2015, Marisa Peters, then 33, noticed blood on the toilet paper after a bowel movement. Worried, she visited her doctor, who dismissed ...

Colon cancer is the disease characterized by the development of malignant cells in the lining or epithelium of the first and longest portion of the large intestine. Loss of the tumor suppressor ...

Germany’s Merck KGaA is paying $45 million upfront for rights to a potentially first-in-class drug for colorectal cancer (CRC) being developed by New York biotech Inspirna. The agreement gives ...